{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:37:33Z","timestamp":1785515853809,"version":"3.56.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T00:00:00Z","timestamp":1713312000000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC2705101"],"award-info":[{"award-number":["2022YFC2705101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Chongqing Science and Health Joint Medical Research Project","award":["2023GGXM001"],"award-info":[{"award-number":["2023GGXM001"]}]},{"name":"Program for Youth Innovation in Future Medicine, and Chongqing Medical University","award":["W0098"],"award-info":[{"award-number":["W0098"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>This study aimed to observe the efficacy and safety of tacrolimus in the treatment of refractory immunoglobulin A vasculitis nephritis (IgAVN).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Sixteen patients with IgAVN who had been previously treated with cyclophosphamide shock therapy at least five times, some of whom had also received mycophenolate but still had persistent proteinuria, were enrolled. The clinical and pathological data were collected and analysed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The average (mean\u00a0\u00b1\u00a0standard deviation) age at the initial assessment for the group of 16 patients was 10\u00a0\u00b1\u00a02.7\u00a0years. Finally, at the end of their respective follow-up time point, 6 of the 16 patients achieved complete remission (37.5%), 5 achieved partial remission (31.2%), and 5 had no remission (31.2%). A significant difference was found in the median proteinuria before and after a 6-month course of tacrolimus treatment [19.2 (11.2, 31.9) vs 7.8 (4.3, 13.9) mg\/kg\/day] (P\u00a0&amp;lt;\u00a0.05). During the first 6\u00a0months of tacrolimus treatment, all patients\u2019 estimated glomerular filtration rate levels remained normal. The mean tacrolimus blood concentration was 6.0\u00a0\u00b1\u00a02.6\u00a0ng\/mL. The median prednisone dosage was decreased from 10\u00a0mg\/day to 5\u00a0mg\/day, and prednisone was eventually stopped in three individuals. No drug-related adverse effects were observed during treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Tacrolimus has demonstrated efficacy in increasing remission rates, significantly lowering urinary protein levels, and reducing steroid use in children with refractory IgAVN. Further research is required to investigate its optimal blood concentrations, long-term effects and renoprotective properties.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfae115","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T03:00:59Z","timestamp":1713322859000},"source":"Crossref","is-referenced-by-count":11,"title":["The efficacy and safety of tacrolimus in treating refractory IgA vasculitis nephritis: a single-center retrospective study on 16 cases"],"prefix":"10.1093","volume":"17","author":[{"given":"Yueheng","family":"Gan","sequence":"first","affiliation":[{"name":"Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anshuo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders , China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Children's Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders , China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"2024051308560288500_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41584-021-00718-8","article-title":"Global epidemiology of vasculitis","volume":"18","author":"Watts","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2024051308560288500_bib2","doi-asserted-by":"crossref","first-page":"1020231","DOI":"10.3389\/fpubh.2022.1020231","article-title":"Bibliometric analysis of IgA vasculitis nephritis in children from 2000 to 2022","volume":"10","author":"Luo","year":"2022","journal-title":"Front Public Health"},{"key":"2024051308560288500_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jped.2021.01.008","article-title":"Risk factors for renal involvement in Henoch-Sch\u00f6nlein purpura","volume":"97","author":"Kim","year":"2021","journal-title":"J Pediatr (Rio J)"},{"key":"2024051308560288500_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.ajkd.2006.02.178","article-title":"Predictors of outcome in Henoch-Sch\u00f6nlein nephritis in children and adults","volume":"47","author":"Coppo","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2024051308560288500_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","year":"2021","journal-title":"Kidney Int"},{"key":"2024051308560288500_bib6","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1093\/rheumatology\/kez041","article-title":"European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative","volume":"58","author":"Ozen","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"2024051308560288500_bib7","doi-asserted-by":"crossref","first-page":"658845","DOI":"10.3389\/fped.2021.658845","article-title":"Using MEST-C scores and the International Study of Kidney Disease in Children classification to predict outcomes of Henoch-Sch\u00f6nlein Purpura nephritis in children","volume":"9","author":"Wang","year":"2021","journal-title":"Front Pediatr"},{"key":"2024051308560288500_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/bcp.14174","article-title":"Off-label use of tacrolimus in children with glomerular disease: effectiveness, safety and pharmacokinetics","volume":"86","author":"Hao","year":"2020","journal-title":"Br J Clin Pharmacol"},{"key":"2024051308560288500_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s12519-019-00257-z","article-title":"Efficacy and safety of tacrolimus and low-dose prednisone in Chinese children with steroid-resistant nephrotic syndrome","volume":"16","author":"Chen","year":"2020","journal-title":"World J Pediatr"},{"key":"2024051308560288500_bib10","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.3892\/etm.2016.3523","article-title":"Tacrolimus combined with low-dose corticosteroids is an effective and safe therapeutic option for refractory IgA nephropathy","volume":"12","author":"Wan","year":"2016","journal-title":"Exp Ther Med"},{"key":"2024051308560288500_bib11","doi-asserted-by":"crossref","first-page":"e224492","DOI":"10.1001\/jamanetworkopen.2022.4492","article-title":"Effect of Tacrolimus vs intravenous cyclophosphamide on complete or partial response in patients with lupus nephritis: a randomized clinical trial","volume":"5","author":"Zheng","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2024051308560288500_bib12","first-page":"647","article-title":"Evidence-based guideline for diagnosis and treatment of Henoch-Schonlein purpura nephritis (2016)","volume":"55","year":"2017","journal-title":"Chin J Pediatr"},{"key":"2024051308560288500_bib13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s40272-022-00506-1","article-title":"Efficacy and safety of Tacrolimus in the treatment of pediatric Henoch-Sch\u00f6nlein purpura nephritis","volume":"24","author":"Wu","year":"2022","journal-title":"Paediatr Drugs"},{"key":"2024051308560288500_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/archdischild-2017-313788","article-title":"Off-label use of tacrolimus in children with Henoch-Sch\u00f6nlein purpura nephritis: a pilot study","volume":"103","author":"Zhang","year":"2018","journal-title":"Arch Dis Child"},{"key":"2024051308560288500_bib15","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bmj.2.6081.262-d","article-title":"Prognosis of Henoch-Sch\u00f6nlein nephritis in children","volume":"2","author":"Derham","year":"1977","journal-title":"Br Med J"},{"key":"2024051308560288500_bib16","first-page":"S2","article-title":"Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies, and chronic interstitial nephritides","volume":"54","author":"Bohle","year":"1996","journal-title":"Kidney Int Suppl"},{"key":"2024051308560288500_bib17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00467-017-3608-5","article-title":"The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Sch\u00f6nlein purpura nephritis","volume":"32","author":"Koskela","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"2024051308560288500_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/nep.14193","article-title":"Value of the modified semiquantitative classification in predicting outcomes in children with Henoch-Sch\u00f6nlein purpura nephritis","volume":"28","author":"Wang","year":"2023","journal-title":"Nephrology (Carlton)"},{"key":"2024051308560288500_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2014.126","article-title":"Henoch-Sch\u00f6nlein purpura nephritis in children","volume":"10","author":"Davin","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"2024051308560288500_bib20","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12969-019-0311-z","article-title":"Different histological classifications for Henoch-Sch\u00f6nlein purpura nephritis: which one should be used?","volume":"17","author":"Jelusic","year":"2019","journal-title":"Pediatr Rheumatol Online J"},{"key":"2024051308560288500_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/hcl034","article-title":"Henoch Sch\u00f6nlein purpura with nephritis in adults: adverse prognostic indicators in a UK population","volume":"99","author":"Shrestha","year":"2006","journal-title":"QJM"},{"key":"2024051308560288500_bib22","first-page":"4633","article-title":"Higher pathological grading is associated with unfavorable outcome of Henoch-Schonlein purpura nephritis in children","volume":"9","author":"Fu","year":"2016","journal-title":"Int J Clin Exp Pathol"},{"key":"2024051308560288500_bib23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2215\/CJN.11461017","article-title":"The spectrum of biopsy-proven glomerular diseases among children in China: a national, cross-sectional survey","volume":"13","author":"Nie","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024051308560288500_bib24","doi-asserted-by":"crossref","first-page":"699","DOI":"10.5301\/jn.5000267","article-title":"Twenty-three-year review of disease patterns from renal biopsies: an experience from a pediatric renal center","volume":"26","author":"Yin","year":"2013","journal-title":"J Nephrol"},{"key":"2024051308560288500_bib25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF00442205","article-title":"Long term renal prognosis of Henoch-Sch\u00f6nlein purpura in an unselected childhood population","volume":"147","author":"Stewart","year":"1988","journal-title":"Eur J Pediatr"},{"key":"2024051308560288500_bib26","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3109\/00365590903164480","article-title":"Early high-dose immunosuppression in Henoch-Sch\u00f6nlein nephrotic syndrome may improve outcome","volume":"43","author":"Andersen","year":"2009","journal-title":"Scand J Urol Nephrol"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfae115\/57245677\/sfae115.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/5\/sfae115\/57569129\/sfae115.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/17\/5\/sfae115\/57569129\/sfae115.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:24:08Z","timestamp":1715592248000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfae115\/7646862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfae115","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,5]]},"published":{"date-parts":[[2024,4,16]]},"article-number":"sfae115"}}